Format

Send to

Choose Destination
Oncogene. 1999 Aug 26;18(34):4879-83.

Smad2 and Smad4 gene mutations in hepatocellular carcinoma.

Author information

1
Department of Molecular Biology and Genetics, Bilkent University 06533 Bilkent, Ankara, Turkey.

Abstract

TGF-beta is a negative regulator of liver growth. Smad family of genes, as mediators of TGF-beta pathway, are candidate tumor suppressor genes in hepatocellular carcinoma (HCC). We studied 35 HCC and non-tumour liver tissues for possible mutations in Smad2 and Smad4 genes. Three tumours displayed somatic mutations; two in Smad4 (Asp332Gly and Cys401Arg) and one in Smad2 (Gln407Arg) genes. All three mutations were A:T --> G:C transitions suspected to result from oxidative stress as observed in mitochondrial DNA. These observation demonstrate that TGF-beta pathway is altered in hepatocellular carcinoma.

PMID:
10490821
DOI:
10.1038/sj.onc.1202866
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center